Substituted Stilbenes as Inhibitors of NF-kappaB and Activators of Nrf2

    公开(公告)号:US20190160021A1

    公开(公告)日:2019-05-30

    申请号:US16204085

    申请日:2018-11-29

    Applicant: STC.UNM

    Abstract: The present invention relates to substituted stilbenes and dienones which exhibit unexpected dual activity, as inhibitors of NFκB and as agonists (activators) of Nrf2. In particular, these compounds show dual activity and makes them particularly useful in the treatment of inflammation, including chronic inflammation and a number of related chronic disease states and conditions, including neurological diseases, including Alzheimer's, Alzheimer's prodrome and mild cognitive impairment, and other diseases and conditions, such as Parkinson's disease, depression, bipolar disorders and autism spectrum disorders. Compounds, pharmaceutical compositions and methods of treatment are described.

Patent Agency Ranking